RNU6-168P

Across TCGA pan-cancer cohorts, RNU6-168P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-168P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU6-168P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-168P expression acts as an unfavorable survival marker.

SKCM, UCEC, and STAD are the cancer types where RNU6-168P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.153	0.783	<.001	108	view →
UCEC	DFS	Tertile	All	0.283	0.654	<.001	54	view →
STAD	OS	Tertile	All	0.385	0.741	.015	27	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-168P–SKCM (OS)

Open the SKCM breakdown →